Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl versus remifentanil for hemodynamic stability in pediatric tonsillectomy/adenoidectomy
IRCT20250713066479N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Jul 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fentanyl, remifentanil, propofol and midazolam in Adenotonsillar hypertrophy (ATH) (2 arms), sponsored by Kerman University of Medical Sciences. Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 2 more. Started Jul 2025; status: completed.
02
Drugs
fentanylremifentanilpropofolmidazolam
03
Conditions
Adenotonsillar hypertrophy (ATH)
Beyond the preview
Go deeper on IRCT20250713066479N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250713066479N1.